Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Nanostructured Lipid Carriers can improve curcumin's effectiveness for treating hair loss.

Acetyl tetrapeptide-3 was successfully made for use in hair loss treatments.

A new acne cream effectively reduced acne in trials and awaits FDA approval.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Acitretin treatment unexpectedly darkened a patient's gray hair.

Lactobacillus acidophilus substances can kill and stop the spread of cervical cancer cells.

The detoxification process made Abrus precatorius seeds safe and effective for use.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

The guideline recommends using specific drugs and surgery together for treating hidradenitis suppurativa effectively.

Ashwagandha may help reduce symptoms of adrenal hyperplasia.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Curcuma aeruginosa rhizome extracts show potential as anticancer agents, with varying effectiveness against breast cancer cells.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Apremilast showed mixed results for treating severe alopecia areata.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Intralesional triamcinolone acetonide effectively treats acne keloidalis nuchae with minimal side effects.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

A baby with maple syrup urine disease improved from skin problems by adjusting his diet to correct amino acid levels.